SE

Sridhar Etikhala Reddy

Active Director Director DIN 07714532
DIN 07714532 First appointment Feb 2017 Primary industry Business Services
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2017
Shareholding value β€’β€’β€’β€’ Premium profile

About Sridhar Etikhala Reddy

Data last updated:

Sridhar Etikhala Reddy is a Director at Vantix Pharma Private Limited (since 2017). The company operates in Business Services.

DIN 07714532
Primary Designation Director
Industry Business Services
First Appointment 28 Feb 2017
Oldest Company Age 9 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Vantix Pharma Private Limited U74999TG2017PTC115557
Director28 Feb 20172017Active

Board colleagues of Sridhar Etikhala Reddy

NameDINCompanyDesignation
Pandillapalli Venkateswara Rao00146001Vantix Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Vantix Pharma Private Limited
Premium access

Shareholding and investment profile for Sridhar Etikhala Reddy

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sridhar Etikhala Reddy

Sridhar Etikhala Reddy currently holds 1 directorship: Vantix Pharma Private Limited (Director, since 28 Feb 2017).

Sridhar Etikhala Reddy was first appointed on 28 Feb 2017 as Director at Vantix Pharma Private Limited.

The current boards of Sridhar Etikhala Reddy's companies include Pandillapalli Venkateswara Rao (Vantix Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available